In this specific example, a highly selective immunosorbent was prepared using a β2-microtubulin- (β2M-) specific nanobody to prospectively purify β2M from the blood of patients with dialysis-related amyloidosis (DRA). The gene discussed is B2M; the disease is amyloidosis.